NLS Pharmaceutics Ltd.
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
NLSP | US
Overview
Corporate Details
- ISIN(s):
- CH0523961370 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- THE CIRCLE 6, 0 ZURICH
- Website:
- https://nlspharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system (CNS) disorders. The company is actively developing treatments for sleep-wake disorders, with a particular focus on narcolepsy, aiming to provide safer and more effective therapies to address significant unmet medical needs. NLS Pharmaceutics advances its pipeline of novel CNS therapies and engages in strategic collaborations to develop next-generation treatments, including gene-edited cell therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all NLS Pharmaceutics Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NLS Pharmaceutics Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NLS Pharmaceutics Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
